Bioventus (BVS) Other financing activities (2020 - 2026)
Bioventus (BVS) posted Other financing activities of -$220000.0 for Q1 2026, down 116.72% on a QoQ basis from $1.3 million in Q4 2025, and down 8.37% year-over-year from -$240107.5 in Q1 2025.
Bioventus (BVS) Other financing activities (2020 - 2026) Analysis & Trends
Bioventus' Other financing activities history runs 7 years deep, the most recent figure standing at -$220000.0 for Q1 2026.
- Quarterly Other financing activities fell 8.37% year-over-year to -$220000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $680000.0 (down 41.38% YoY) and the FY2025 annual result came in at $697000.0, down 40.93% from the prior year.
- Other financing activities was -$220000.0 for Q1 2026 at Bioventus, down from $1.3 million in the prior quarter.
- Across five years, Other financing activities topped out at $1.7 million in Q4 2024 and bottomed at -$220000.0 in Q1 2026.
- A 5-year average of $67705.9 and a median of -$168000.0 in 2023 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2023 — Other financing activities slumped 4400.0% — and 2024, when it soared 1113.95%.
- Bioventus' Other financing activities stood at $4000.0 in 2022, then slumped by 4400.0% to -$172000.0 in 2023, then surged by 1113.95% to $1.7 million in 2024, then decreased by 24.54% to $1.3 million in 2025, then sank by 116.72% to -$220000.0 in 2026.
- Business Quant data shows BVS's Other financing activities at -$220000.0 in Q1 2026, $1.3 million in Q4 2025, and -$207000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Bioventus | 837.84 Mn | 801.99 Mn | 90.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -220,000.00 |
| Mar 28, 2026 | -220,000.00 |
| Dec 31, 2025 | 1.32 Mn |
| Dec 31, 2025 | 1.32 Mn |
| Sep 27, 2025 | -207,000.00 |
| Sep 27, 2025 | -207,000.00 |
| Jun 28, 2025 | -209,000.00 |
| Jun 28, 2025 | -209,000.00 |
| Mar 29, 2025 | -203,000.00 |
| Mar 29, 2025 | -203,000.00 |
| Dec 31, 2024 | 1.74 Mn |
| Dec 31, 2024 | 1.74 Mn |
| Sep 28, 2024 | -191,000.00 |
| Sep 28, 2024 | -191,000.00 |
| Jun 29, 2024 | -190,000.00 |
| Jun 29, 2024 | -190,000.00 |
| Mar 30, 2024 | -183,000.00 |
| Mar 30, 2024 | -183,000.00 |
| Dec 31, 2023 | -172,000.00 |
| Dec 31, 2023 | -172,000.00 |